Medicines, 2020
Shortlist up to four to read them side by side.
1,035 medicine recalls FDA’s Enforcement Report published in 2020, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 6, 2026.
1,035of 1,035 medicine recallsshown with your filters
The list
- Medicine recall Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-count bottle (NDC… CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classJan 29, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 29, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ranitidine Tablets, USP 300 mg a). 15-count bottles (NDC 70934-287-15), b). 90-count bottles (NDC… CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classJan 29, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 29, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 150 mg, a) 30 count bottles (NDC: 68788-7388-3), b) 60… CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classJan 29, 2020in FDA’s Enforcement Report7 statesnamed in where it went PublishedJan 29, 2020ClassClass IIStatusTerminatedWhereAlabama, Arizona, California, Florida, Georgia, Indiana and South Carolina
- Medicine recall Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 300 mg CGMP Deviations: Presence of NDMA impurity detected in product. Class IIFDA’s classJan 29, 2020in FDA’s Enforcement Report7 statesnamed in where it went PublishedJan 29, 2020ClassClass IIStatusTerminatedWhereAlabama, Arizona, California, Florida, Georgia, Indiana and South Carolina
- Medicine recall Ranitidine 150 mg tablet Original Supplier’s CGMP Deviation; Received notice from supplier of potential -Nitrosodimethylamine (NDMA) amounts above established levels. Class IIFDA’s classJan 29, 2020in FDA’s Enforcement Report2 statesnamed in where it went PublishedJan 29, 2020ClassClass IIStatusTerminatedWhereCalifornia and New York
- Medicine recall NETSPOT, (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, For Intravenous Use Only Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2). Class IIFDA’s classJan 29, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 29, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Entropic Labs SARM RAD-140, 20mg Capsules, 30-count bottles, Entropic Labs Marketed Without An Approved NDA/ANDA: product contains Selective Androgen Receptor Modulators (SARMs) Class IIFDA’s classJan 29, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 29, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall methylPREDNISolone Sodium Succinate For Injection, USP, 500 mg*/vial Labeling: Incorrect Instructions: Vial label incorrectly instructs healthcare professional to reconstitute product with 16 mL rather than the correct volume of… Class IIIFDA’s classJan 29, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 29, 2020ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Bull Platinum 30000 Capsules, 1000 mg, in orange, white, yellow background with silver text Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil FDA Class I, its most serious class Class IFDA’s class (needs attention)Jan 22, 2020in FDA’s Enforcement ReportTexasthe one state its words name PublishedJan 22, 2020ClassClass IStatusTerminatedWhereTexas
- Medicine recall Stallion Platinum 30000 Capsules in blue,orange,white background with red,white text in hologram paper… Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil FDA Class I, its most serious class Class IFDA’s class (needs attention)Jan 22, 2020in FDA’s Enforcement ReportTexasthe one state its words name PublishedJan 22, 2020ClassClass IStatusTerminatedWhereTexas
- Medicine recall Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologram… Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil FDA Class I, its most serious class Class IFDA’s class (needs attention)Jan 22, 2020in FDA’s Enforcement ReportTexasthe one state its words name PublishedJan 22, 2020ClassClass IStatusTerminatedWhereTexas
- Medicine recall Panther Platinum 30000 Capsules, in green, black background with white, red text in hologram paper packaging Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil FDA Class I, its most serious class Class IFDA’s class (needs attention)Jan 22, 2020in FDA’s Enforcement ReportTexasthe one state its words name PublishedJan 22, 2020ClassClass IStatusTerminatedWhereTexas
- Medicine recall Ketorolac Tromethamine Injection, USP 60 mg/2 mL Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS) Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Sumatriptan Succinate Tablets, 50 mg Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Sumatriptan Succinate Tablets, 100 mg Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Dutasteride Capsules, 0.5 mg, 30 Capsules Failed Impurities/Degradation Specifications: High out of specification results for related compounds. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Alprostadil 40 mcg/mL Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Autologous Serum 20% Eye Drops Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BAC 150 mcg/BUP 2 mg/Hydrom 15 mg/Morp 20 mg/SUF 650 mcg/mL Inj Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BAC 15MCG/HYDROM 15MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BAC 160MCG/HYDROM 16MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BAC 200MCG/ CLONI 250MCG/ MORP 10MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BAC 200MCG/BUP22MG/CLON210MCG/HYDROM 15MG/SUF800MCG/ML ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BAC 225MCG/ BUP 4.5MG/ CLON 9MCG/ MORP 3MG/ML ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BAC 2400MCG/ FENT 2600MCG/ MORP 3600MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BAC 250MCG/ /FENT 3500MCG/ /MORP 25MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BAC 4000MCG /FENT 600MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BAC 400MCG/BUP 20MG/HYDROM 15MG/SUF 1000MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BAC 50MCG/ HYDROM 10MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BAC 800MCG/BUP 6.7MG/CLON 600 MCG/FENT 850MCG/MORP 20MG INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BACLOFEN 2000MCG/ML Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Bi-Mix 30 mg/1 mg/mL Inj Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Bi-Mix Forte 30 mg/2 mg/mL Inj Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BPC-157 2000 mcg/mL Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BUP 10MG/ FENT 1000MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BUP 10MG/HYDROM 10MG/MORP 2MG/SUF 250MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BUP 10MG/HYDROM 15MG/SUF 200MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BUP 15MG/CLON 300MCG/ FENT 1500MCG/ML(40) INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BUP 15MG/CLON 400MCG/ FENT 6000MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BUP 15MG/CLON 600MCG/MORP 30MG/ML Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BUP 15MG/HYDROM 5MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BUP 17MG/MORP 22MG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BUP 1MG//ML/HYDROM 7MG INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BUP 2.5MG/ CLONI 5MCG/ FENT 200MCG/ SUF 50MCG/ML Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BUP 2.5MG/FENT 25MCG/HYDRO 2MG/MORP 40MG/ML Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BUP 20MG/CLON 250MCG/FENT 7200MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BUP 20MG/CLON 300MCG/FENT 2000MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BUP 20MG/SUF 1000MCG/ML INJ Lack of sterility assurance. Class IIFDA’s classJan 22, 2020in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedJan 22, 2020ClassClass IIStatusTerminatedWhereNationwide
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.